Encompass 医疗 EHC
$137.54 −$3.73 (-2.64%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $137.54 0.00%
开盘$137.92
昨收$141.27
当日区间$136.92 – $139.56
成交量1.18M
市值$13.50B
市盈率（TTM）21.5
股息率0.57%
财报
财报日平均波动±5.1%近16次财报
收涨次数12 / 1675% 的概率
最佳反应+12.6%
最差反应-7.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 28 Oct 2026 | After Market | ±6.8% | +7.70% | 超出定价预期 |
| 2026/Q2 | 5 Aug 2026 | After Market | ±8.4% | +12.55% | 超出定价预期 |
| 2026/Q1 | 30 Apr 2026 | After Market | ±7.3% | +7.48% | 超出定价预期 |
| 2025/Q4 | 5 Feb 2026 | After Market | ±6.4% | +5.86% | 符合区间 |
| 2025/Q3 | 29 Oct 2025 | After Market | ±6.9% | -7.02% | 超出定价预期 |
| 2025/Q2 | 4 Aug 2025 | After Market | ±7.4% | +4.00% | 符合区间 |
| 2025/Q1 | 24 Apr 2025 | After Market | ±9.0% | +11.79% | 超出定价预期 |
| 2024/Q4 | 6 Feb 2025 | After Market | ±6.4% | +1.28% | 符合区间 |
| 2024/Q3 | 28 Oct 2024 | After Market | ±6.6% | +7.42% | 超出定价预期 |
| 2024/Q2 | 5 Aug 2024 | After Market | ±5.9% | -5.56% | 符合区间 |
| 2024/Q1 | 24 Apr 2024 | After Market | ±7.9% | -0.08% | 符合区间 |
| 2023/Q4 | 7 Feb 2024 | After Market | ±5.7% | +0.95% | 符合区间 |
| 2023/Q3 | 26 Oct 2023 | After Market | ±7.2% | -0.62% | 符合区间 |
| 2023/Q2 | 1 Aug 2023 | After Market | ±5.4% | +5.09% | 符合区间 |
| 2023/Q1 | 27 Apr 2023 | None | ±6.6% | +1.12% | 符合区间 |
| 2022/Q4 | 7 Feb 2023 | After Market | ±5.5% | +2.70% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.60B+9.6% YoY
营业利润$288.40M+11.3% YoY
净利润$207.40M+12.2% YoY
摊薄每股收益$1.54+10.8% YoY
自由现金流$62.30M-45.0% YoY
经营现金流$282.60M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率95.8%
营业利润率18.0%
净利率10.0%
净资产收益率25.4%
资产收益率8.7%
投入资本回报率13.8%
流动比率1.19
负债/资产比率53.6%
现金及投资$107.70M
总负债$2.81B
净现金（净负债）-$2.71B
自由现金流/营收6.7%
暂无评论——快来第一个聊聊 EHC。
登录后参与讨论。